Ulcerative Colitis Clinical Trials

Showing 6441-6460 of 7,290 trials

Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

NCT00619489

This was an open-label study to provide an opportunity for participants with Ulcerative Colitis (UC) who previously completed Study C13002 (NCT01177228), and for treatment-naïve participants with UC or Crohn's Disease (CD) to receive treatment with vedolizumab, and to determine the long term safety of vedolizumab in patients afflicted with these diseases.

Ulcerative ColitisCrohn's Disease

Millennium Pharmaceuticals, Inc.72 participantsStarted Dec 2007

London, Ontario, Canada

COMPLETEDNA

After Discharge Management of Low Income Frail Elderly

NCT00328848

The purpose of this study is to determine whether comprehensive post-hospitalization interdisciplinary care management can be an effective care delivery model to improve outcomes in low-income frail elderly.

Heart Failure, CongestiveCoronary ArteriosclerosisAtrial Fibrillation+6 more

Summa Health System530 participantsStarted Oct 2005

COMPLETEDPhase 3

Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease

NCT02177344

The objective of this study is to confirm that chronic dosing of 20 mcg and 40 mcg of ipratropium bromide, administered via the RESPIMAT device, demonstrates clinical comparability and similar safety profiles to the 36 mcg dose of ATROVENT® Inhalation Aerosol (containing chlorinated fluorocarbons (CFC)) in patients with chronic obstructive pulmonary disease (COPD). The efficacy and safety profiles of the two doses administered via the RESPIMAT device will also be compared to their respective placebo groups

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim646 participantsStarted Aug 1998

Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

After Discharge Management of Low Income Frail Elderly

Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease

Related Searches

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension

A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α

Safety and Efficacy of Travoprost/Timolol BAC-free

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

Patient Preference Study

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension

Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II

Risk of Acute Liver Injury in Users of Antimicrobials

Lactose, Sucrose & Corn Syrup Tolerance

Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

World Trade Center (WTC) CHEST

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease

Evaluation of a New Medical Device AL539 in Patients With Obstructive Apneas Sleep Syndrome

Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)

Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1